4/A//SEC Filing
ROSE ERIC A MD 4/A
Accession 0001213900-23-041634
CIK 0001814114other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:02 PM ET
Size
6.7 KB
Accession
0001213900-23-041634
Insider Transaction Report
Form 4/AAmended
ROSE ERIC A MD
Director
Transactions
- Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+23,250→ 23,250 totalExercise: $10.00Exp: 2032-08-17→ Common Stock (23,250 underlying)
Footnotes (3)
- [F1]On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently misstated the expiration date of one class of nonstatutory stock options ("NSOs"). In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to correct the incorrect expiration date in Table II, Column 6 to August 17, 2032; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.
- [F2]The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares will vest on the first anniversary of the grant date and (ii) 67% of the underlying shares will vest in equal installments on a quarterly basis starting on the day of the month of the last month of the first quarter after the first anniversary of the grant date, that is the same day of the month as the grant date, subject to the Reporting Person's continuous service through such date. The grant date is August 18, 2022.
- [F3]Received in the Business Combination in exchange for a nonstatutory stock option to acquire 50,000 shares of Legacy Orchestra Common Stock for $4.65 per share.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001139301
Filing Metadata
- Form type
- 4/A
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 6:02 PM ET
- Size
- 6.7 KB